{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:22:37Z","timestamp":1760235757977,"version":"build-2065373602"},"reference-count":53,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1179074"],"award-info":[{"award-number":["APP1179074"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Duchenne muscular dystrophy (DMD) is characterized by progressive muscle weakness and wasting due to the lack of dystrophin protein. The acute phase of DMD is characterized by muscle necrosis and increased levels of the pro-inflammatory mediator, prostaglandin D2 (PGD2). Inhibiting the production of PGD2 by inhibiting hematopoietic prostaglandin D synthase (HPGDS) may alleviate inflammation and decrease muscle necrosis. We tested our novel HPGDS inhibitor, PK007, in the mdx mouse model of DMD. Our results show that hindlimb grip strength was two-fold greater in the PK007-treated mdx group, compared to untreated mdx mice, and displayed similar muscle strength to strain control mice (C57BL\/10ScSn). Histological analyses showed a decreased percentage of regenerating muscle fibers (~20% less) in tibialis anterior (TA) and gastrocnemius muscles and reduced fibrosis in the TA muscle in PK007-treated mice. Lastly, we confirmed that the DMD blood biomarker, muscle creatine kinase activity, was also reduced by ~50% in PK007-treated mdx mice. We conclude that our HPGDS inhibitor, PK007, has effectively reduced muscle inflammation and fibrosis in a DMD mdx mouse model.<\/jats:p>","DOI":"10.3390\/life11090994","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T22:34:01Z","timestamp":1632263641000},"page":"994","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hematopoietic Prostaglandin D Synthase Inhibitor PK007 Decreases Muscle Necrosis in DMD mdx Model Mice"],"prefix":"10.3390","volume":"11","author":[{"given":"Sai","family":"Yarlagadda","sequence":"first","affiliation":[{"name":"School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, QLD 4072, Australia"},{"name":"Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Kulis","sequence":"additional","affiliation":[{"name":"Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9821-8478","authenticated-orcid":false,"given":"Peter G.","family":"Noakes","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, QLD 4072, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark L.","family":"Smythe","sequence":"additional","affiliation":[{"name":"Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.4045\/tidsskr.13.0836","article-title":"Duchenne muscular dystrophy","volume":"134","author":"Annexstad","year":"2014","journal-title":"Tidsskr. Nor. Laegeforen."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/adc.68.5.632","article-title":"Functional significance of dystrophin positive fibres in Duchenne muscular dystrophy","volume":"68","author":"Nicholson","year":"1993","journal-title":"Arch. Dis. Child."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/0028-3886.43441","article-title":"Duchenne muscular dystrophy","volume":"56","author":"Yiu","year":"2008","journal-title":"Neurol. India"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/S0140-6736(98)10028-4","article-title":"Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in the Netherlands: A cohort study","volume":"353","author":"Hoogerwaard","year":"1999","journal-title":"Lancet"},{"key":"ref_5","first-page":"592","article-title":"Early symptoms of Duchenne muscular dystrophy\u2014description of cases of an 18-month-old and an 8-year-old patient","volume":"6","author":"Stawarski","year":"2001","journal-title":"Med. Sci. Monit."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1083\/jcb.128.3.355","article-title":"Mechanical function of dystrophin in muscle cells","volume":"128","author":"Pasternak","year":"1995","journal-title":"J. Cell Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1083\/jcb.200208085","article-title":"Prostaglandin F2\u03b1 stimulates growth of skeletal muscle cells via an NFATC2-dependent pathway","volume":"161","author":"Horsley","year":"2003","journal-title":"J. Cell Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"493618","DOI":"10.1155\/2012\/493618","article-title":"Various Jobs of Proteolytic Enzymes in Skeletal Muscle during Unloading: Facts and Speculations","volume":"2012","author":"Kachaeva","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"8823","DOI":"10.3390\/molecules20058823","article-title":"Current Understanding of Molecular Pathology and Treatment of Cardiomyopathy in Duchenne Muscular Dystrophy","volume":"20","author":"Betts","year":"2015","journal-title":"Molecules"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Gomez-Cabrera, M.C., Vi\u00f1a, J., and Ji, L.L. (2016). Role of Redox Signaling and Inflammation in Skeletal Muscle Adaptations to Training. Antioxidants, 5.","DOI":"10.3390\/antiox5040048"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1128\/iai.64.12.4883-4890.1996","article-title":"Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy","volume":"64","author":"Roord","year":"1996","journal-title":"Infect. Immun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1440-1681.2007.04868.x","article-title":"Implications of Cross-Talk between Tumour Necrosis Factor and Insulin-Like Growth Factor-1 Signalling in Skeletal Muscle","volume":"35","author":"Grounds","year":"2008","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.biopha.2018.12.034","article-title":"Duchenne muscular dystrophy: Focus on arachidonic acid metabolites","volume":"110","author":"Hoxha","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.tips.2012.02.004","article-title":"Prostaglandins and chronic inflammation","volume":"33","author":"Aoki","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.2353\/ajpath.2009.080709","article-title":"Inhibition of Prostaglandin D Synthase Suppresses Muscular Necrosis","volume":"174","author":"Mohri","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1073\/pnas.1705420114","article-title":"Prostaglandin E2 is essential for efficacious skeletal muscle stem-cell function, augmenting regeneration and strength","volume":"114","author":"Ho","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/926968","article-title":"PGI2as a Regulator of Inflammatory Diseases","volume":"2012","author":"Dorris","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00401-002-0567-z","article-title":"Induction of hematopoietic prostaglandin D synthase in hyalinated necrotic muscle fibers: Its implication in grouped necrosis","volume":"104","author":"Okinaga","year":"2002","journal-title":"Acta Neuropathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"15277","DOI":"10.1074\/jbc.M506431200","article-title":"Structural and Functional Characterization of HQL-79, an Orally Selective Inhibitor of Human Hematopoietic Prostaglandin D Synthase","volume":"281","author":"Aritake","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/dvdy.22726","article-title":"Hematopoietic prostaglandin D synthase (H-Pgds) is expressed in the early embryonic gonad and participates to the initial nuclear translocation of the SOX9 protein","volume":"240","author":"Moniot","year":"2011","journal-title":"Dev. Dyn."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1523\/JNEUROSCI.4531-05.2006","article-title":"Prostaglandin D2-Mediated Microglia\/Astrocyte Interaction Enhances Astrogliosis and Demyelination in twitcher","volume":"26","author":"Mohri","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/acn3.651","article-title":"A phase I study of TAS-205 in patients with Duchenne muscular dystrophy","volume":"5","author":"Takeshita","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.nmd.2014.06.102","article-title":"Novel inhibitor of hematopoietic prostaglandin D synthase improves the muscle disorder in an experimental model of Duchenne muscular dystrophy","volume":"24","author":"Tanaka","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrrheum.2014.2","article-title":"The skeletal muscle arachidonic acid cascade in health and inflammatory disease","volume":"10","author":"Korotkova","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2008.03.008","article-title":"Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy","volume":"31","author":"Grounds","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1111\/febs.12267","article-title":"The mdx mouse model as a surrogate for Duchenne muscular dystrophy","volume":"280","author":"Partridge","year":"2013","journal-title":"FEBS J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13395-017-0149-3","article-title":"Myoblast fusion confusion: The resolution begins","volume":"8","author":"Sampath","year":"2018","journal-title":"Skelet. Muscle"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00441-018-2955-2","article-title":"Skeletal muscle fibrosis: An overview","volume":"375","author":"Mahdy","year":"2019","journal-title":"Cell Tissue Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2613.2003.00354.x","article-title":"Duchenne\u2019s muscular dystrophy: Animal models used to investigate pathogenesis and develop therapeutic strategies","volume":"84","author":"Collins","year":"2003","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_32","unstructured":"TREAT-NMD (2021, July 13). Experimental Protocols for DMD Animal Models. Available online: https:\/\/treat-nmd.org\/research-overview\/preclinical-research\/experimental-protocols-for-dmd-animal-models\/."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e2279","DOI":"10.21769\/BioProtoc.2279","article-title":"Muscle Histology Characterization Using H&E Staining and Muscle Fiber Type Classification Using Immunofluorescence Staining","volume":"7","author":"Wang","year":"2017","journal-title":"Bio-Protocol"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3233\/JND-200556","article-title":"Mechanisms and Clinical Applications of Glucocorticoid Steroids in Muscular Dystrophy","volume":"8","author":"Quattrocelli","year":"2021","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/mus.20646","article-title":"Weekly oral prednisolone improves survival and strength in male mdx mice","volume":"35","author":"Keeling","year":"2007","journal-title":"Muscle Nerve"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.nmd.2007.02.005","article-title":"Strength and corticosteroid responsiveness of mdx mice is unchanged by RAG2 gene knockout","volume":"17","author":"Golumbek","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/(SICI)1097-4598(199612)19:12<1576::AID-MUS7>3.0.CO;2-7","article-title":"Deflazacort but not prednisone improves both muscle repair and fiber growth in diaphragm and limb muscle in vivo in the mdx dystrophic mouse","volume":"19","author":"Anderson","year":"1996","journal-title":"Muscle Nerve"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/acn3.50978","article-title":"Early phase 2 trial of TAS-205 in patients with Duchenne muscular dystrophy","volume":"7","author":"Komaki","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"M\u00e2ncio, R.D., Hermes, T.D.A., Macedo, A.B., Mizobuti, D.S., Rupcic, I.F., and Minatel, E. (2017). Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0182449"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0022-510X(94)90026-4","article-title":"Anabolic steroid treatment increases myofiber damage in mdx mouse muscular dystrophy","volume":"125","author":"Krahn","year":"1994","journal-title":"J. Neurol. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1023\/A:1014587918367","article-title":"Tibialis anterior muscles in mdx mice are highly susceptible to contraction-induced injury","volume":"22","author":"DelloRusso","year":"2001","journal-title":"J. Muscle Res. Cell Motil."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Rittchen, S., and Heinemann, A. (2019). Therapeutic Potential of Hematopoietic Prostaglandin D2 Synthase in Allergic Inflammation. Cells, 8.","DOI":"10.3390\/cells8060619"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1590\/S0100-879X2002000600009","article-title":"Impaired regeneration of dystrophin-deficient muscle fibers is caused by exhaustion of myogenic cells","volume":"35","author":"Luz","year":"2002","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"965631","DOI":"10.1155\/2014\/965631","article-title":"Understanding the Process of Fibrosis in Duchenne Muscular Dystrophy","volume":"2014","author":"Kharraz","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_45","first-page":"1","article-title":"Biomarkers of Duchenne muscular dystrophy: Current findings","volume":"8","author":"Szigyarto","year":"2018","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.braindev.2018.06.012","article-title":"Urinary prostaglandin metabolites as Duchenne muscular dystrophy progression markers","volume":"40","author":"Takeshita","year":"2018","journal-title":"Brain Dev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1006974613418","article-title":"Creatine kinase, cell membrane and Duchenne muscular dystrophy","volume":"190","author":"Ozawa","year":"1999","journal-title":"Mol. Cell. Biochem."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Gutpell, K.M., Hrinivich, W.T., and Hoffman, L.M. (2015). Skeletal muscle fibrosis in the mdx\/utrn+\/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0117306"},{"key":"ref_49","unstructured":"Sakuma, K. (2018). Molecular and Cellular Markers in Skeletal Muscle Damage after Acute Voluntary Exercise Containing Eccentric Muscle Contractions. Muscle Cell and Tissue, IntechOpen. Available online: https:\/\/www.intechopen.com\/chapters\/61489."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e12391","DOI":"10.14814\/phy2.12391","article-title":"Disease course in mdx:utrophin+\/- mice: Comparison of three mouse models of Duchenne muscular dystrophy","volume":"3","author":"McDonald","year":"2015","journal-title":"Physiol. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1093\/hmg\/11.26.3333","article-title":"Prevention of pathology in mdx mice by expression of utrophin: Analysis using an inducible transgenic expression system","volume":"11","author":"Squire","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"14070","DOI":"10.1038\/s41598-020-70987-y","article-title":"The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy","volume":"10","author":"Hammers","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13395-015-0041-y","article-title":"Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia","volume":"5","author":"Duddy","year":"2015","journal-title":"Skelet. Muscle"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/11\/9\/994\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:02:59Z","timestamp":1760166179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/11\/9\/994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,21]]},"references-count":53,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["life11090994"],"URL":"https:\/\/doi.org\/10.3390\/life11090994","relation":{},"ISSN":["2075-1729"],"issn-type":[{"type":"electronic","value":"2075-1729"}],"subject":[],"published":{"date-parts":[[2021,9,21]]}}}